Helmut Brunar

Dr. Helmut Brunar is an executive with broad experience in the pharma and biotech sector. Before joining as Viravaxx’ CEO, he managed supply chain activities at Johnson & Johnson’s COVID-19 vaccine program in The Netherlands. Prior to this, he was founder, CEO & Chairman at Axentis Pharma AG of Switzerland where within 11 years he built the company from scratch to develop and position respiratory drug candidate AX-TOBRA, a drug-device combination in the anti-infectives area.